Literature DB >> 26640305

Chapter 13. A3 Adenosine Receptors.

Kenneth A Jacobson1, Susanna Tchilibon1, Bhalchandra V Joshi1, Zhan-Guo Gao1.   

Abstract

Year:  2003        PMID： 26640305      PMCID： PMC4668118          DOI： 10.1016/S0065-7743(03)38014-5

Source DB:  PubMed          Journal:  Annu Rep Med Chem        ISSN： 0065-7743            Impact factor:   1.059


× No keyword cloud information.
  50 in total

1.  Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats.

Authors:  E A Van Schaick; K A Jacobson; H O Kim; A P IJzerman; M Danhof
Journal:  Eur J Pharmacol       Date:  1996-07-25       Impact factor: 4.432

2.  Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke.

Authors:  D K Von Lubitz; K L Simpson; R C Lin
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

3.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

4.  Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.

Authors:  C A Salvatore; S L Tilley; A M Latour; D S Fletcher; B H Koller; M A Jacobson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

5.  Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.

Authors:  Pier Giovanni Baraldi; Barbara Cacciari; Stefano Moro; Giampiero Spalluto; Giorgia Pastorin; Tatiana Da Ros; Karl-Norbert Klotz; Katia Varani; Stefania Gessi; Pier Andrea Borea
Journal:  J Med Chem       Date:  2002-02-14       Impact factor: 7.446

6.  Adenosine A(3) receptor-mediated potentiation of mucociliary transport and epithelial ciliary motility.

Authors:  Manako Taira; Jun Tamaoki; Kazuyuki Nishimura; Junko Nakata; Mitsuko Kondo; Hisashi Takemura; Atsushi Nagai
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-03       Impact factor: 5.464

7.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.

Authors:  Michael P DeNinno; Hiroko Masamune; Lois K Chenard; Kenneth J DiRico; Cynthia Eller; John B Etienne; Jeanene E Tickner; Scott P Kennedy; Delvin R Knight; Jimmy Kong; Joseph J Oleynek; W Ross Tracey; Roger J Hill
Journal:  J Med Chem       Date:  2003-01-30       Impact factor: 7.446

9.  2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.

Authors:  Vita Ozola; Mark Thorand; Martina Diekmann; Ramatullah Qurishi; Britta Schumacher; Kenneth A Jacobson; Christa E Müller
Journal:  Bioorg Med Chem       Date:  2003-02-06       Impact factor: 3.641

10.  N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.

Authors:  Zhan-Guo Gao; Joshua B Blaustein; Ariel S Gross; Neli Melman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2003-05-15       Impact factor: 5.858
View more
  2 in total

1.  Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.

Authors:  Zafer Sahin; Sevde Nur Biltekin; Leyla Yurttas; Barkin Berk; Yağmur Özhan; Hande Sipahi; Zhan-Guo Gao; Kenneth A Jacobson; Şeref Demirayak
Journal:  Eur J Med Chem       Date:  2020-12-31       Impact factor: 6.514

Review 2.  Progress in the pursuit of therapeutic adenosine receptor antagonists.

Authors:  Stefano Moro; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Med Res Rev       Date:  2006-03       Impact factor: 12.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.